RedHill Biopharma Completes Private Placement for Up To $19.4 Million
RedHill Biopharma has completed a private placement offering, raising approximately $6 million upfront with potential additional proceeds of up to $13.4 million from warrant exercises. The funds are intended to strengthen the company's liquidity and support a possible acquisition of commercial-stage pharmaceutical assets.
Tickers: $RDHL